Effects of Intralipid on myocardial dysfunction and SAFE pathway signaling following ex vivo global ischemia-reperfusion.

Cour M, Hadebe NE, Imamdin A, Stevic N, Abrahams C, Swanevelder J, Lecour S

Open source

DOI
10.1016/j.yexmp.2026.105047
Published
2026 Jun
Container
Experimental and molecular pathology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.yexmp.2026.105047,
  title = {Effects of Intralipid on myocardial dysfunction and SAFE pathway signaling following ex vivo global ischemia-reperfusion.},
  author = {Cour M and Hadebe NE and Imamdin A and Stevic N and Abrahams C and Swanevelder J and Lecour S},
  year = {2026},
  journal = {Experimental and molecular pathology},
  doi = {10.1016/j.yexmp.2026.105047},
  url = {https://doi.org/10.1016/j.yexmp.2026.105047}
}

RIS

TY  - JOUR
TI  - Effects of Intralipid on myocardial dysfunction and SAFE pathway signaling following ex vivo global ischemia-reperfusion.
AU  - Cour M
AU  - Hadebe NE
AU  - Imamdin A
AU  - Stevic N
AU  - Abrahams C
AU  - Swanevelder J
AU  - Lecour S
PY  - 2026
JO  - Experimental and molecular pathology
DO  - 10.1016/j.yexmp.2026.105047
UR  - https://doi.org/10.1016/j.yexmp.2026.105047
ER  - 

APA

M, C., NE, H., A, I., N, S., C, A., J, S., & S, L. (2026). Effects of Intralipid on myocardial dysfunction and SAFE pathway signaling following ex vivo global ischemia-reperfusion.. Experimental and molecular pathology. https://doi.org/10.1016/j.yexmp.2026.105047

Source records